Buy Jounce Therapeutics Stock | JNCE Stock Price & Latest News | Public.com
JNCE

Jounce Therapeutics

$0.00 (0.00%)Today
    Small Market Cap
    View Jounce Therapeutics (JNCE) stock trends here

    About JNCE

    Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which treat cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients. Its products pipeline include JTX-2011 (ICOS); JTX-4014 (PD-1); ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.86
    0.3
    -0.26
    -0.82
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.34

    Actual EPS
    Q1 2021

    Stats

    Market Cap$437,56M
    Volume239,24k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$14.08
    1 Year Low$2.85
    Open$12.15
    High$12.15
    Low$10.88

    Buy any stock with any amount of money.

    Download the App
    Download the app